摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Chloro-2-methyl-3-phenylpropanoic acid | 1011-87-6

中文名称
——
中文别名
——
英文名称
2-Chloro-2-methyl-3-phenylpropanoic acid
英文别名
2-chloro-2-methyl-3-phenyl-propionic acid;2-Chlor-2-methyl-3-phenyl-propionsaeure;2-Benzyl-2-chlor-propionsaeure
2-Chloro-2-methyl-3-phenylpropanoic acid化学式
CAS
1011-87-6
化学式
C10H11ClO2
mdl
——
分子量
198.649
InChiKey
FMENLZZIIPYTOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 盐酸甲酸 作用下, 生成 2-Chloro-2-methyl-3-phenylpropanoic acid
    参考文献:
    名称:
    Dombrowskii et al., Zhurnal Obshchei Khimii, 1957, vol. 27, p. 3346,3347; engl. Ausg. S. 3381
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • AMINOACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF MIXED DISULFANYL AND AMINOPEPTIDASE N INHIBITORS
    申请人:Roques Bernard
    公开号:US20090012153A1
    公开(公告)日:2009-01-08
    The invention relates to novel compounds of formula (I): H 2 N—CH(R 1 )—CH 2 —S—S—CH 2 —CH(R 2 )—CONH—R 5 , wherein R 1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R 2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R 5 is a CH(R 3 )—COOR 4 radical, wherein R 3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR 4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C 1 -C 6 , phenyl or benzyl radical. The use of the inventive compounds in the form of drugs, a pharmaceutical composition comprising said compounds, a pharmaceutically acceptable excipient, the use in conjunction of at least one type of cannabinoid derivative for potentiating the analgesic and antidepressant effect of the novel compounds of formula (I) and/or morphine or the derivatives thereof are also disclosed.
    该发明涉及式(I)的新化合物:H2N—CH(R1)—CH2—S—S—CH2—CH(R2)—CONH—R5,其中R1是一个碳氢链、苯基或苯甲基基团,甲基基团被一个5或6原子杂环取代;R2是一个苯基或苯甲基基团,一个5或6原子芳香杂环,甲基基团被一个5或6原子杂环取代;R5是一个CH(R3)—COOR4基团,其中R3是氢、一个OH或OR基团、一个饱和碳氢基团、一个苯基或苯甲基基团,OR4是亲水酯基,或者由氮、硫和氧组成的几个杂原子选自的5或6元杂环,至少有两个氮原子,其中所述杂环可被一个烷基C1-C6、苯基或苯甲基基团取代。该发明化合物的用途包括作为药物、包含所述化合物的药物组合物、药用可接受的赋形剂,以及与至少一种大麻素衍生物联合使用以增强式(I)式新化合物的镇痛和抗抑郁效果和/或吗啡或其衍生物的效果。
  • Alkylation, Acylation, and Cyclopropanation Reactions of<i>a</i>-Halo Carboxylic Acid Dianions
    作者:Carl R. Johnson、Thomas R. Bade
    DOI:10.1055/s-1982-29781
    日期:——
  • COSMETIC SKIN CONDITIONING COMPOSITIONS
    申请人:UNILEVER PLC
    公开号:EP0980239A1
    公开(公告)日:2000-02-23
  • Aminoacid Derivatives Containing a Disulfanyl Group in the form of Mixed Disulfanyl and Aminopeptidase N Inhibitors
    申请人:Roques Bernard
    公开号:US20090131509A1
    公开(公告)日:2009-05-21
    The invention relates to novel compounds of formula (I): H 2 N—CH(R 1 )—CH 2 —S—S—CH 2 —CH(R 2 )—COONH—R 5 , wherein R 1 is a hydrocarbon chain, phenyl or benzyl radical, methylene radical substituted by a 5 or 6 atom heterocycle; R 2 is a phenyl or benzyl radical, a 5 or 6 atom aromatic heterocycle, methylene group substituted by a 5 or 6 atom heterocycle; R 5 is a CH(R 3 )—COOR 4 radical, wherein R 3 is hydrogen, an OH or OR group, a saturated hydrocarbon group, a phenyl or benzyl radical and OR 4 is hydrophile ester, or 5 or 6 membered heterocycle comprising several heteroatoms selected from a group consisting of nitrogen, sulphur and oxygen, with at least two nitrogene atoms, wherein said heterocycle is substitutable by an alkyl C 1 -C 6 , phenyl or benzyl radical. The use of the inventive compounds in the form of drugs, a pharmaceutical composition comprising said compounds, a pharmaceutically acceptable excipient, the use in conjunction of at least one type of cannabinoid derivative for potentiating the analgesic and antidepressant effect of the novel compounds of formula (I) and/or morphine or the derivatives thereof are also disclosed.
  • US4670579A
    申请人:——
    公开号:US4670579A
    公开(公告)日:1987-06-02
查看更多